Alzheimer's Drug Discovery Foundation

Summary

Alzheimer's Drug Discovery Foundation is the famous Corporate Investor, which was founded in 1998. The main department of described Corporate Investor is located in the New York. The fund was located in North America if to be more exact in United States.

The fund was created by Leonard Lauder, Ronald S. Lauder.

This Alzheimer's Drug Discovery Foundation works on 11 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Genetics, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Metabolic Solutions Development, Oryzon Genomics, AgeneBio. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Alzheimer's Drug Discovery Foundation, startups are often financed by National Institutes of Health, Hopen Life Science Ventures, Dolby Family Ventures. The meaningful sponsors for the fund in investment in the same round are Dolby Family Ventures, W Fund, National Institutes of Health. In the next rounds fund is usually obtained by W Fund, Michael Montgomery, Kayne Anderson Capital Advisors.